Clinical Research Directory
Browse clinical research sites, groups, and studies.
Real-life Assessment of Abilify Maintena + Rexult in Schizophrenia
Sponsor: The University of Hong Kong
Summary
MainRexult study aims to carefully evaluate a cohort of patients with schizophrenia and related disorder prescribed with the combination therapy with Abilify Maintena and Rexulti on its efficacy and tolerability in a real-life clinical setting.
Official title: Real-life Assessment of Aripiprazole Long-acting Injection (Abilify Maintena) Combined With Brexpiprazole (Rexulti) in Schizophrenia: a Naturalistic Non-interventional Prospective Follow-up Study
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
OBSERVATIONAL
Enrollment
10
Start Date
2022-02-01
Completion Date
2026-01-31
Last Updated
2025-07-09
Healthy Volunteers
Not specified
Interventions
ARIPiprazole Injection [Abilify]
subject already receiving the combination of Abilify Maintena and Rexulti
Brexpiprazole
subject already receiving the combination of Abilify Maintena and Rexulti
Locations (1)
Queen Mary Hospital
Hong Kong, Hong Kong